Literature DB >> 27437918

Genotype-dependent Metabolic Responses to Semi-Purified High-Sucrose High-Fat Diets in the TALLYHO/Jng vs. C57BL/6 Mouse during the Development of Obesity and Type 2 Diabetes.

J K Parkman1, X Mao1, K Dillon1, A Gudivada1, N Moustaid-Moussa2, A M Saxton3, J H Kim1.   

Abstract

Background: The co-epidemic of obesity and type 2 diabetes is associated with increased morbidity and mortality. Genetic factors are highly involved in the development of these diseases, in the form of interactions of multiple genes within obesogenic and diabetogenic environments, such as a high fat diet. The TALLYHO/Jng (TH) mouse is an inbred polygenic model for human obesity and type 2 diabetes. In order to further develop the TH mouse as a clinically relevant model, we investigated diet dependence of obesity and type 2 diabetes in TH mice vs. C57BL/6 (B6) mice.
Results: TH and B6 mice were weaned onto a standard rodent chow, semi-purified high-sucrose low-fat (HSLF), or semi-purified high-sucrose high-fat (HSHF) diet and maintained on these diets throughout the study. Despite similar fat contents in HSLF diets and chow, both B6 and TH mice responded to HSLF diets, with increases in adiposity. TH mice, but not B6 mice, exhibited significantly higher adiposity with severely aggravated glucose intolerance and hyperglycemia on HSHF diets compared to the other diets. HSLF diets also advanced diabetes in TH mice compared to chow, but it did not surpass the effects of HSHF diets. The severe glucose intolerance and hyperglycemia in TH mice on both HSLF and HSHF diets were accompanied by significantly reduced Glut4 mRNA levels compared to B6 mice. Conclusions: The present data demonstrate that diets are important modulators of genetic susceptibility to type 2 diabetes and obesity in TH mice. The interplay between heredity and dietary environment in TH mice appears to amplify insulin resistance, contributing to severe glucose intolerance and diabetes. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27437918     DOI: 10.1055/s-0042-109605

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Can Diabetes Be Controlled by Lifestyle Activities?

Authors:  P Hemachandra Reddy
Journal:  Curr Res Diabetes Obes J       Date:  2017-03-20

2.  Mitochondrial oxidative phosphorylation is impaired in TALLYHO mice, a new obesity and type 2 diabetes animal model.

Authors:  Caroline A Hunter; Funda Kartal; Zeynep C Koc; Tamara Murphy; Jung Han Kim; James Denvir; Emine C Koc
Journal:  Int J Biochem Cell Biol       Date:  2019-09-19       Impact factor: 5.085

3.  Congenic mice demonstrate the presence of QTLs conferring obesity and hypercholesterolemia on chromosome 1 in the TALLYHO mouse.

Authors:  Jacaline K Parkman; James Denvir; Xia Mao; Kristy D Dillon; Sofia Romero; Arnold M Saxton; Jung Han Kim
Journal:  Mamm Genome       Date:  2017-10-05       Impact factor: 2.957

4.  Effects of high fat diets and supplemental tart cherry and fish oil on obesity and type 2 diabetes in male and female C57BL/6J and TALLYHO/Jng mice.

Authors:  Jacaline K Parkman; Kristiana Sklioutovskaya-Lopez; Kalhara R Menikdiwela; Logan Freeman; Naima Moustaid-Moussa; Jung Han Kim
Journal:  J Nutr Biochem       Date:  2021-04-07       Impact factor: 6.117

5.  Inhibition of intestinal villus cell Na/K-ATPase mediates altered glucose and NaCl absorption in obesity-associated diabetes and hypertension.

Authors:  Balasubramanian Palaniappan; Subha Arthur; Vijaya Lakshmi Sundaram; Molly Butts; Shanmuga Sundaram; Kathiresh Mani; Soudamani Singh; Niraj Nepal; Uma Sundaram
Journal:  FASEB J       Date:  2019-05-20       Impact factor: 5.834

6.  Effects of the amount and type of carbohydrates used in type 2 diabetes diets in animal models: A systematic review.

Authors:  Anaísa Martins Marques; Bárbara Silva Linhares; Rômulo Dias Novaes; Mariella Bontempo Freitas; Mariáurea Matias Sarandy; Reggiani Vilela Gonçalves
Journal:  PLoS One       Date:  2020-06-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.